Drive-through model for anticoagulation clinics during the COVID-19 pandemic

K Rezaei Bookani, I Minga, M Chander… - Clinical and Applied …, 2020 - journals.sagepub.com
K Rezaei Bookani, I Minga, M Chander, K Hankewych, M Plassmeier, A Tafur
Clinical and Applied Thrombosis/Hemostasis, 2020journals.sagepub.com
The coronavirus disease of 2019 (COVID-19) has posed a major challenge for providers
and patients. A large number of patients with atrial fibrillation, venous thromboembolism, or
valvular heart disease are chronically anticoagulated with vitamin K antagonists and rely on
frequent follow ups at anticoagulation clinics for management of their anticoagulation
therapy. The need for isolation during COVID-19 pandemic can potentially limit access to
health care including anticoagulation clinics and directly affect the care of patients on …
The coronavirus disease of 2019 (COVID-19) has posed a major challenge for providers and patients. A large number of patients with atrial fibrillation, venous thromboembolism, or valvular heart disease are chronically anticoagulated with vitamin K antagonists and rely on frequent follow ups at anticoagulation clinics for management of their anticoagulation therapy. The need for isolation during COVID-19 pandemic can potentially limit access to health care including anticoagulation clinics and directly affect the care of patients on chronic anticoagulation. Therefore, we created a drive-through clinic to bridge the gap of continuation of care and preservation of social distancing precautions. In this manuscript, we report the steps in implementing such initiative which can be applied to other clinics during a pandemic.
Sage Journals
以上显示的是最相近的搜索结果。 查看全部搜索结果